Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (249)	1/10/2007 5:03:18 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 360

Mike; Compare GLGC with GHDX. Aren't they kind of doing the same thing? Success vrs failure? I know a long time ago when GLGC picked up, uhhh was it oncogene - something like that. That was in the late 90's I believe and was how I first became a GLGC shareholder. One of the things that oncogene (again sp?) brought that I thought was of value was a "tissue bank". What they were doing was watching how cancers developed by watching what genes were being turned off and on. Maybe in their overzealous growth, GLGC took their eyes off the ball - PROFITS? I must admit I do not follow GHDX at all - wish I had of - but looks to me that they are doing the diagnostics of differing genes. What a concept! steve